Xenon Pharmaceuticals Inc.
XENE· Nasdaq
XENEXenon Pharmaceuticals Inc.
Filed Mar 8, 2016 · 10-K · 68 days after period end · 0001564590-16-014222
| Metric | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|
| Revenue | $3.23M | $4.88M | $5.58M |
| Net Income | -$3.94M | $1.22M | — |
| EPS Diluted | -$0.27 | $0.13 | $1.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 8, 2016 · 68 d after period end
